Usted buscó: transgenskih (Esloveno - Inglés)

ruksolitinib prav tako ni bil kancerogen v modelu tg.rash2 transgenskih miši.
ruxolitinib was not carcinogenic in the tg.rash2 transgenic mouse model.

konestat alfa je pridobljen iz mleka transgenskih kuncev in vsebuje sledove kunčjih beljakovin.
conestat alfa is derived from milk of transgenic rabbits and contains traces of rabbit protein.

kancerogenost so ocenjevali v dvoletni študiji na podganah in v šestmesečni študiji na transgenskih miših.
carcinogenicity was assessed in a two-year rat study and a six-month transgenic mouse study.

da je zdravilo ruconest pridobljeno iz mleka transgenskih kuncev in vsebuje sledove kunčjih beljakovin;
that ruconest is derived from milk of transgenic rabbits and contains trace of rabbit proteins

rekombinantni humani antitrombin se proizvaja s tehnologijo rekombinantne dna (rdna) v mleku transgenskih koz.
recombinant human antithrombin produced in the milk of transgenic goats by recombinant dna technology (rdna).

antitrombin alfa je rekombinantna oblika humanega antitrombina, ki se proizvaja z rekombinantno dna tehnologijo v mleku transgenskih koz.
antithrombin alfa is a recombinant form of human antithrombin and is produced by recombinant dna technology in the milk of transgenic goats.

v študiji za presojo potencialne kancerogenosti na transgenskih rash miših niso opažali, da bi se incidence neoplastičnih lezij povečale v zvezi z zdravljenjem.
in a study to assess potential carcinogenicity in transgenic rash2 mice, no treatment related increases in the incidence of neoplastic lesions were observed.

v 2-letni študiji na podganah in v 6-mesečni študiji na transgenskih miših niso zasledili karcinogenega potenciala.
no carcinogenic potential for aliskiren was detected in a 2-year rat study and a 6-month transgenic mouse study.

Študije na transgenskih miših kažejo, da ima (starani) tekoči nutropin majhen potencial za spodbujanje tvorbe protiteles.
studies in transgenic mice suggest a low antibody provoking potential of (aged) liquid nutropin.

konestat alfa je rekombinantni analog humanega zaviralca esteraze c1 (rhc1inh), pridobljen s tehnologijo rekombinantne dna v mleku transgenskih kuncev.
conestat alfa is the recombinant analogue of the human c1 esterase inhibitor (rhc1inh) produced by recombinant dna technology in the milk of transgenic rabbits.

karcinogeni potencial so ocenjevali v 2- letni študiji na podganah in v 6- mesečni študiji na transgenskih miših: karcinogenega potenciala niso zasledili.
no carcinogenic potential was detected.

deferasiroks ni bil karcinogen, ko so ga uporabili pri podganah v 2-letni študiji in transgenskih p53+/- heterozigotnih miših v 6-mesečni študiji.
deferasirox was not carcinogenic when administered to rats in a 2-year study and transgenic p53+/- heterozygous mice in a 6-month study.

v 6-mesečnih študijah kancerogenosti na transgenskih miših so opazili zvečano incidenco benignih granulozocelularnih tumorjev na jajčnikih samic, ki so prejemale 150 ali 500 mg/kg/dan.
in 6-month carcinogenicity studies in transgenic mice, there was an increased incidence of benign, ovarian granulosa-cell tumours in female mice given 150 or 500 mg/kg/day.

dasabuvir v 6-mesečni študiji transgenskih miši ni bil kancerogen vse do največjega testiranega odmerka (2 g/kg/dan), ob čemer je bila izpostavljenost dasabuvirju glede na auc 19-krat večja od izpostavljenosti pri človeku ob priporočenem odmerku 500 mg (250 mg dvakrat na dan).
dasabuvir was not carcinogenic in a 6-month transgenic mouse study up to the highest dosage tested (2 g/kg/day), resulting in dasabuvir auc exposures approximately 19-fold higher than those in humans at the recommended dose of 500 mg (250 mg twice daily).